Page last updated: 2024-08-16

tiopronin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

tiopronin has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bakker, D; Hollmann, MW; Nederlof, R; Renkema, H; Smeitink, JAM; Weber, NC; Xiao, Y; Yim, K; Zhang, H; Zuurbier, CJ	1

Other Studies

1 other study(ies) available for tiopronin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

Article	Year
The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury. Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:4 Topics: Aldehydes; Animals; Antioxidants; Chromans; Disease Models, Animal; Mice; Myocardial Reperfusion Injury; Oxidation-Reduction; Oxidative Stress; Time-to-Treatment; Tiopronin; Treatment Outcome	2021

Article

Year

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury.

Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:4

Topics: Aldehydes; Animals; Antioxidants; Chromans; Disease Models, Animal; Mice; Myocardial Reperfusion Injury; Oxidation-Reduction; Oxidative Stress; Time-to-Treatment; Tiopronin; Treatment Outcome

2021